Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Biotechnology » HBI-2840816
  • Global Genotyping Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: August 2016 | Report Code: HBI-2840816

* For 15% discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Growing developments in technologies, declining prices of DNA sequencing, growing prevalence of genetic diseases such as hemophilia, thalassemia etc., rising importance of SNP genotyping for the drug development process and growing demand for genome exploration in animal and plant livestock are the major factor that are increasing the growth in the global genotyping market. Moreover, the growing demand for personalized medicine due to increasing aging population across the globe is also impacting the growth of the global market. The world is currently on the edge of undertaking a demographic milestone. Subsequently the establishment of history being recorded, young children previously were ahead of the number of people aged 65 or more will go down in the coming future. The change is motivated by dropping fertility rates and noteworthy rise in life expectancy, population aging is expected to continue, even accelerate in the next 10 years. The total people aged 65 or older are projected to raise from an assessed 524 million in year 2010 to almost 1.5 billion in year 2050, with most of the increase in developing countries. As per WHO the world aged population is estimated to reach 2 billion by the end of 2050 that is 900 million in 2015. The remarkable improvements in life expectancy over the past century were part of a shift in the leading causes of disease and death. The rising prevalence of chronic life style oriented diseases is also increasing the growth in the global genotyping market.  Cancer is the major disease which is increasing with a huge pace, according to WHO, by the end of 2020 there are around 15 million people is projected to suffer from cancer which increases by around 50%. Although, Nonexistence of Suitable Reimbursement Policies, Lack of Technical Expertise and High Cost of research and development are the major factor that are hampering the growth in the global genotyping market. Moreover, there are some factors such as growing access to healthcare & rising investment in emerging markets, growing demand for reasonably priced genotyping services, growing application extents of genotyping and growing demand from emerging economies are creating huge opportunity in the global market in the near future.

The global Genotyping market is estimated to register robust growth and is expected to grow at CAGR of 23% during 2016-2022. The Genotyping market is segmented on the basis of technology, product, application and geography. The technology segment is segmented into Polymerase Chain Reaction(PCR), Capillary Electrophoresis, Mass Spectrometry, Sequencing, Microarray and Other. The application segment is segmented into Diagnostics, Drug Discovery and Development, Personalized Medicine, Academic Research, Agriculture and Others.  The product segment is segmented into instrument, reagents and kits and services. Polymerase Chain Reaction (PCR) is the important technology that is being used by researchers and healthcare professionals for precise and fast detection of genetic changes. The introduction of innovative Polymerase Chain Reaction (PCR) technologies in combination with computer programs, such as inverse PCR, reverse transcription PCR, assembly PCR and Quantitative PCR (Q-PCR) is also anticipated to driving the market growth. Sequencing is anticipated to be the fastest growing technology segment. Numerous advances in the present sequencing technologies have changed sequencing into a flexible, multilayered molecular tool.

On the basis of geography North America, Europe, Asia Pacific and ROW are the major segments. The North America hold the largest market share around 32% in 2015 and dominated  the global market followed by Europe, Asia Pacific and ROW in the global Genotyping market. The growth in North America market is majorly driven by the presence of some key player of genotyping who are investing a huge amount for the development of new technology in the genome development which is increasing the North America share in the Global genotyping market. The growth of North America is driven by number of factors such as Declining Prices of DNA Sequencing, Growing Prevalence of Genetic Diseases, rising funding from private and government for new technological advancement in genotyping technology and increasing demand for the personalized medicine in the North American region. Asia Pacific market is expected to grow with a high CAGR in forecasted period. The demand in the Asia Pacific region is majorly driven by rising demand for personalized medicine for the treatment due to increasing number of patient population in the region and increasing prevalence of chronic owing to change in the lifestyle and increase in the disposable income of the people. Moreover, the growing aging population in the emerging countries such as India and China is creating huge demand for the low cost treatment in the region and driving the growth in the global market.

1.    INTRODUCTION
1.1.    EXECUTIVE SUMMARY
1.2.    MARKET SCOPE
 
2.    MARKET OVERVIEW
2.1.    GLOBAL GENOTYPING MARKET: EVOLUTION & TRANSITION
2.2.    INDUSTRY STRUCTURE
2.3.    MANUFACTURING PROCESS
2.4.    REGULATORY FRAMEWORK
2.5.    TOTAL MARKET ANALYSIS
2.5.1.    TOP 5 FINDINGS
2.5.2.    TOP 5 OPPORTUNITY MARKETS
2.5.3.    TOP 5 COMPANIES
2.5.4.    TOP 3 COMPETITIVE STRATEGIES
2.6.    ESTIMATION ANALYSIS
2.6.1.    SHARE OF GENOTYPING IN GLOBAL ELECTRONIC NICOTINE DELIVERY SYSTEMS MARKET
2.6.2.    DEMAND OF GENOTYPING
2.6.3.    REVENUE OF TOP 5 MARKET PLAYERS
2.7.    STRATEGIC ANALYSIS
2.7.1.    INVESTMENT VS. ADOPTION MODEL
2.7.2.    360 DEGREE INDUSTRY ANALYSIS
2.7.3.    PORTERS 5 FORCE MODEL
2.7.4.    SEE-SAW ANALYSIS
2.7.5.    CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7.6.    ROI ANALYSIS
2.7.7.    GAP ANALYSIS
2.8.    COMPETITIVE ANALYSIS
2.8.1.    KEY STRATEGIES AND ANALYSIS
2.8.2.    MARKET SHARE
2.8.3.    TOP COMPANY ANALYSIS
2.9.    STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1.    INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2.    OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3.    INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3.    MARKET DETERMINANTS
3.1.    MARKET DRIVERS & MARKET IMPACT
3.1.1.    GROWING DEVELOPMENTS IN TECHNOLOGIES
3.1.2.    DECLINING PRICES OF DNA SEQUENCING
3.1.3.    GROWING PREVALENCE OF GENETIC DISEASES
3.1.4.    INCREASING PERSONALIZED MEDICINE
3.1.5.    RISING IMPORTANCE OF SNP GENOTYPING FOR THE DRUG DEVELOPMENT PROCESS
3.1.6.    GROWING DEMAND FOR GENOME EXPLORATION IN ANIMAL AND PLANT LIVESTOCK
3.2.    MARKET RESTRAINTS & MARKET IMPACT
3.2.1.    NONEXISTENCE OF SUITABLE REIMBURSEMENT POLICIES
3.2.2.    LACK OF TECHNICAL EXPERTISE
3.2.3.    HIGH COST OF RESEARCH AND DEVELOPMENT
3.3.    MARKET OPPORTUNITIES
3.3.1.    GROWING ACCESS TO HEALTHCARE & RISING INVESTMENT IN EMERGING MARKETS
3.3.2.    GROWING DEMAND FOR REASONABLY PRICED GENOTYPING SERVICES
3.3.3.    GROWING APPLICATION EXTENTS OF GENOTYPING
3.3.4.    GROWING DEMAND FROM EMERGING ECONOMIES
3.4.    MARKET CHALLENGES
3.4.1.    MARKET CONSOLIDATION IS HAMPERING THE GROWTH
3.4.2.    COHESIVE GOVERNMENT REGULATION
 
4.    MARKET SEGMENTATION
4.1.    GLOBAL GENOTYPING MARKET BY TECHONOLOGY 2014-2023 ($ MILLION)
4.1.1.    MARKET DEFINITION AND SCOPE
4.1.2.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4.    OPPORTUNITY MATRIX
4.1.5.    MARKET SEGMENTATION
4.1.5.1.    CAPILLARY ELECTROPHORESIS 2014-2023 ($ MILLION)
4.1.5.1.1.    APPLICATIONS
4.1.5.1.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.1.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5.    KEY CONCLUSIONS
4.1.5.2.    MASS SPECTROMETRY 2014-2023 ($ MILLION)
4.1.5.2.1.    APPLICATIONS
4.1.5.2.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.2.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5.    KEY CONCLUSIONS
4.1.5.3.    MICROARRAY 2014-2023 ($ MILLION)
4.1.5.3.1.    APPLICATIONS
4.1.5.3.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3.1.    UNIT SHIPMENTS (MT) 2014-2023 ($ MILLION)
4.1.5.3.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.3.3.3.    PRICE ANALYSIS
4.1.5.3.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5.    KEY CONCLUSIONS
4.1.5.4.    POLYMERASE CHAIN REACTION(PCR) 2014-2023 ($ MILLION)
4.1.5.4.1.    APPLICATIONS
4.1.5.4.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3.1.    UNIT SHIPMENTS (MT) 2014-2023 ($ MILLION)
4.1.5.4.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.4.3.3.    PRICE ANALYSIS
4.1.5.4.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5.    KEY CONCLUSIONS
4.1.5.5.    SEQUENCING2014-2023 ($ MILLION)
4.1.5.5.1.    APPLICATIONS
4.1.5.5.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.3.1.    UNIT SHIPMENTS (MT) 2014-2023 ($ MILLION)
4.1.5.5.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.5.3.3.    PRICE ANALYSIS
4.1.5.5.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.5.5.    KEY CONCLUSIONS
4.1.5.6.    OTHERS 2014-2023 ($ MILLION)
4.1.5.6.1.    APPLICATIONS
4.1.5.6.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.3.1.    UNIT SHIPMENTS (MT) 2014-2023 ($ MILLION)
4.1.5.6.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
4.1.5.6.3.3.    PRICE ANALYSIS
4.1.5.6.4.    TOP PLAYERS & KEY PRODUCTS
4.1.5.6.5.    KEY CONCLUSIONS
4.2.    GLOBAL GENOTYPING MARKET BY PRODUCT 2014-2023 ($ MILLION)
4.2.1.    MARKET DEFINITION AND SCOPE
4.2.2.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4.    OPPORTUNITY MATRIX
4.2.5.    MARKET SEGMENTATION
4.2.5.1.    INSTRUMENTS 2014-2023 ($ MILLION)
4.2.5.1.1.    APPLICATIONS
4.2.5.1.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.2.5.1.4.    TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5.    KEY CONCLUSIONS
4.2.5.2.    REAGENTS AND KITS 2014-2023 ($ MILLION)
4.2.5.2.1.    APPLICATIONS
4.2.5.2.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.2.5.2.4.    TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5.    KEY CONCLUSIONS
4.2.5.3.    SERVICES 2014-2023 ($ MILLION)
4.2.5.3.1.    APPLICATIONS
4.2.5.3.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.2.5.3.4.    TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5.    KEY CONCLUSIONS
4.3.    GLOBAL GENOTYPING MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.3.1.    MARKET DEFINITION AND SCOPE
4.3.2.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4.    OPPORTUNITY MATRIX
4.3.5.    MARKET SEGMENTATION
4.3.5.1.    ACADEMIC RESEARCH 2014-2023 ($ MILLION)
4.3.5.1.1.    APPLICATIONS
4.3.5.1.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.1.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5.    KEY CONCLUSIONS
4.3.5.2.    AGRICULTURE 2014-2023 ($ MILLION)
4.3.5.2.1.    APPLICATIONS
4.3.5.2.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.2.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5.    KEY CONCLUSIONS
4.3.5.3.    DIAGNOSTICS 2014-2023 ($ MILLION)
4.3.5.3.1.    APPLICATIONS
4.3.5.3.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.3.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5.    KEY CONCLUSIONS
4.3.5.4.    DRUG DISCOVERY AND DEVELOPMENT 2014-2023 ($ MILLION)
4.3.5.4.1.    APPLICATIONS
4.3.5.4.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.4.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5.    KEY CONCLUSIONS
4.3.5.5.    PERSONALIZED MEDICINE 2014-2023 ($ MILLION)
4.3.5.5.1.    APPLICATIONS
4.3.5.5.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.5.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.5.5.    KEY CONCLUSIONS
4.3.5.6.    OTHERS 2014-2023 ($ MILLION)
4.3.5.6.1.    APPLICATIONS
4.3.5.6.2.    ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.3.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.6.3.1.    MARKET REVENUES 2014-2023 ($ MILLION)
4.3.5.6.4.    TOP PLAYERS & KEY PRODUCTS
4.3.5.6.5.    KEY CONCLUSIONS
 
5.    COMPETITIVE LANDSCAPE
5.1.    KEY STRATEGIES
5.1.1.    LIST OF M&A
5.1.2.    LIST OF JV
5.1.3.    LIST OF PRODUCT LAUNCHES
5.1.4.    LIST OF PARTNERSHIP
5.2.    TOP 10 COMPANY ANALYSIS – DASHBOARD
 
6.    GLOBAL GENOTYPING MARKET BY REGION (REVENUE ANALYSIS) 2014-2023 ($ MILLION)
6.1.    DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2.    COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3.    OPPORTUNITY MATRIX
6.4.     GEOGRAPHIC SEGMENTATION
6.4.1.    NORTH AMERICA
6.4.1.1.    INDUSTRY APPLICATION ANALYSIS
6.4.1.2.    TOP COUNTRY ANALYSIS
6.4.1.2.1.    U.S.
6.4.1.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.1.2.1.3.    TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.4.    KEY CONCLUSIONS
6.4.1.2.2.    CANADA
6.4.1.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.1.2.2.3.    TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.4.    KEY CONCLUSIONS
6.4.2.    EUROPE
6.4.2.1.    INDUSTRY APPLICATION ANALYSIS
6.4.2.2.    TOP COUNTRY ANALYSIS
6.4.2.2.1.    UK
6.4.2.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.1.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.4.    KEY CONCLUSIONS
6.4.2.2.2.    FRANCE
6.4.2.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.2.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.4.    KEY CONCLUSIONS
6.4.2.2.3.    GERMANY
6.4.2.2.3.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.3.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.4.    KEY CONCLUSIONS
6.4.2.2.4.    SPAIN
6.4.2.2.4.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.4.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.4.    KEY CONCLUSIONS
6.4.2.2.5.    ITALY
6.4.2.2.5.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.5.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.4.    KEY CONCLUSIONS
6.4.2.2.6.    REST OF EUROPE
6.4.2.2.6.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.6.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.2.2.6.3.    TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.4.    KEY CONCLUSIONS
6.4.3.    ASIA PACIFIC
6.4.3.1.    INDUSTRY APPLICATION ANALYSIS
6.4.3.2.    TOP COUNTRY ANALYSIS
6.4.3.2.1.    CHINA
6.4.3.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.1.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.4.    KEY CONCLUSIONS
6.4.3.2.2.    INDIA
6.4.3.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.2.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.4.    KEY CONCLUSIONS
6.4.3.2.3.    JAPAN
6.4.3.2.3.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.3.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.4.    KEY CONCLUSIONS
6.4.3.2.4.    SOUTH KOREA
6.4.3.2.4.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.4.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.4.    KEY CONCLUSIONS
6.4.3.2.5.    AUSTRALIA
6.4.3.2.5.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.5.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.4.    KEY CONCLUSIONS
6.4.3.2.6.    REST OF ASIA PACIFIC
6.4.3.2.6.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.6.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.3.2.6.3.    TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.4.    KEY CONCLUSIONS
6.4.4.    ROW
6.4.4.1.    INDUSTRY APPLICATION ANALYSIS
6.4.4.2.    TOP COUNTRY ANALYSIS
6.4.4.2.1.    LATIN AMERICA
6.4.4.2.1.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.4.2.1.3.    TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.4.    KEY CONCLUSIONS
6.4.4.2.2.    MIDDLE EAST & AFRICA
6.4.4.2.2.1.    MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2.    MARKET REVENUES 2014-2023 ($ MILLION)
6.4.4.2.2.3.    TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.4.    KEY CONCLUSIONS
 
7.    COMPANY PROFILES
7.1.    AFFYMETRIX, INC.
7.1.1.    OVERVIEW
7.1.2.    PRODUCT PORTFOLIO
7.1.3.    KEY INNOVATION SECTOR
7.1.4.    STRATEGIC INITIATIVES
7.1.5.    SCOT ANALYSIS
7.2.    AGILENT TECHNOLOGIES
7.2.1.    OVERVIEW
7.2.2.    PRODUCT PORTFOLIO
7.2.3.    KEY INNOVATION SECTOR
7.2.4.    STRATEGIC INITIATIVES
7.2.5.    SCOT ANALYSIS
7.3.    BECKMAN COULTER    
7.3.1.    OVERVIEW
7.3.2.    PRODUCT PORTFOLIO
7.3.3.    KEY INNOVATION SECTOR
7.3.4.    STRATEGIC INITIATIVES
7.3.5.    SCOT ANALYSIS
7.4.    BIOGENICQ
7.4.1.    OVERVIEW
7.4.2.    PRODUCT PORTFOLIO
7.4.3.    KEY INNOVATION SECTOR
7.4.4.    STRATEGIC INITIATIVES
7.4.5.    SCOT ANALYSIS
7.5.    FLUIDIGM CORP.
7.5.1.    OVERVIEW
7.5.2.    PRODUCT PORTFOLIO
7.5.3.    KEY INNOVATION SECTOR
7.5.4.    STRATEGIC INITIATIVES
7.5.5.    SCOT ANALYSIS
7.6.    GE HEALTHCARE
7.6.1.    OVERVIEW
7.6.2.    PRODUCT PORTFOLIO
7.6.3.    KEY INNOVATION SECTOR
7.6.4.    STRATEGIC INITIATIVES
7.6.5.    SCOT ANALYSIS
7.7.    GENETICHEALTH
7.7.1.    OVERVIEW
7.7.2.    PRODUCT PORTFOLIO
7.7.3.    KEY INNOVATION SECTOR
7.7.4.    STRATEGIC INITIATIVES
7.7.5.    SCOT ANALYSIS
7.8.    GENEWIZ, INC.
7.8.1.    OVERVIEW
7.8.2.    PRODUCT PORTFOLIO
7.8.3.    KEY INNOVATION SECTOR
7.8.4.    STRATEGIC INITIATIVES
7.8.5.    SCOT ANALYSIS
7.9.    HARLAN LABORATORIES
7.9.1.    OVERVIEW
7.9.2.    PRODUCT PORTFOLIO
7.9.3.    KEY INNOVATION SECTOR
7.9.4.    STRATEGIC INITIATIVES
7.9.5.    SCOT ANALYSIS
7.10.    HELIX
7.10.1.    OVERVIEW
7.10.2.    PRODUCT PORTFOLIO
7.10.3.    KEY INNOVATION SECTOR
7.10.4.    STRATEGIC INITIATIVES
7.10.5.    SCOT ANALYSIS
7.11.    ILLUMINA, INC
7.11.1.    OVERVIEW
7.11.2.    PRODUCT PORTFOLIO
7.11.3.    KEY INNOVATION SECTOR
7.11.4.    STRATEGIC INITIATIVES
7.11.5.    SCOT ANALYSIS
7.12.    QIAGEN NV
7.12.1.    OVERVIEW
7.12.2.    PRODUCT PORTFOLIO
7.12.3.    KEY INNOVATION SECTOR
7.12.4.    STRATEGIC INITIATIVES
7.12.5.    SCOT ANALYSIS
7.13.    ROCHE
7.13.1.    OVERVIEW
7.13.2.    PRODUCT PORTFOLIO
7.13.3.    KEY INNOVATION SECTOR
7.13.4.    STRATEGIC INITIATIVES
7.13.5.    SCOT ANALYSIS
7.14.    SEQUENOM INC.
7.14.1.    OVERVIEW
7.14.2.    PRODUCT PORTFOLIO
7.14.3.    KEY INNOVATION SECTOR
7.14.4.    STRATEGIC INITIATIVES
7.14.5.    SCOT ANALYSIS
7.15.    THERMOFISHER SCIENTIFIC
7.15.1.    OVERVIEW
7.15.2.    PRODUCT PORTFOLIO
7.15.3.    KEY INNOVATION SECTOR
7.15.4.    STRATEGIC INITIATIVES
7.15.5.    SCOT ANALYSIS
 
LIST OF TABLES
1.    GLOBAL GENOTYPING MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
2.    GLOBAL CAPILLARY ELECTROPHORESIS BY GEOGRAPHY 2014-2023 ($ MILLION)
3.    GLOBAL MASS SPECTROMETRY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4.    GLOBAL MICROARRAY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5.    GLOBAL POLYMERASE CHAIN REACTION(PCR) BY GEOGRAPHY 2014-2023 ($ MILLION)
6.    GLOBAL SEQUENCING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7.    GLOBAL OTHER MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8.    GLOBAL GENOTYPING MARKET BY PRODUCT 2014-2023 ($ MILLION)
9.    GLOBAL INSTRUMENTS BY GEOGRAPHY 2014-2023 ($ MILLION)
10.    GLOBAL REAGENTS AND KITS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11.    GLOBAL SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12.    GLOBAL GENOTYPING MARKET IN APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
13.    GLOBAL GENOTYPING MARKET IN ACADEMIC RESEARCH BY GEOGRAPHY 2014-2023 ($ MILLION)
14.    GLOBAL GENOTYPING MARKET IN AGRICULTURE BY GEOGRAPHY 2014-2023 ($ MILLION)
15.    GLOBAL GENOTYPING MARKET IN DIAGNOSTICS BY GEOGRAPHY 2014-2023 ($ MILLION)
16.    GLOBAL GENOTYPING MARKET IN DRUG DISCOVERY AND DEVELOPMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
17.    GLOBAL GENOTYPING MARKET IN PERSONALIZED MEDICINE BY GEOGRAPHY 2014-2023 ($ MILLION)
18.    GLOBAL GENOTYPING MARKET IN OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)
19.    NORTH AMERICA GENOTYPING MARKET 2014-2023 ($ MILLION)
20.    EUROPE GENOTYPING MARKET 2014-2023 ($ MILLION)
21.    ASIA PACIFIC GENOTYPING MARKET 2014-2023 ($ MILLION)
22.    REST OF THE WORLD GENOTYPING MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
23.    GLOBAL GENOTYPING  MARKET BY INSTRUMENTS MARKET 2014-2023 ($ MILLION)
24.    GLOBAL GENOTYPING MARKET BY REAGENTS AND KITS MARKET 2014-2023 ($ MILLION)
25.    GLOBAL GENOTYPING MARKET BY SERVICES MARKET 2014-2023 ($ MILLION)
26.    GLOBAL GENOTYPING MARKET BY CAPILLARY ELECTROPHORESIS MARKET 2014-2023 ($ MILLION)
27.    GLOBAL GENOTYPING MARKET BY MASS SPECTROMETRY MARKET 2014-2023 ($ MILLION)
28.    GLOBAL GENOTYPING MARKET BY MICROARRAY MARKET 2014-2023 ($ MILLION)
29.    GLOBAL GENOTYPING MARKET BY POLYMERASE CHAIN REACTION(PCR) MARKET 2014-2023 ($ MILLION)
30.    GLOBAL GENOTYPING MARKET BY SEQUENCING MARKET 2014-2023 ($ MILLION)
31.    GLOBAL GENOTYPING MARKET BY OTHERS MARKET 2014-2023 ($ MILLION)
32.    GLOBAL GENOTYPING MARKET BY ACADEMIC RESEARCH MARKET 2014-2023 ($ MILLION)
33.    GLOBAL GENOTYPING MARKET BY AGRICULTURE MARKET 2014-2023 ($ MILLION)
34.    GLOBAL GENOTYPING MARKET BY DIAGNOSTICS MARKET 2014-2023 ($ MILLION)
35.    GLOBAL GENOTYPING MARKET BY DRUG DISCOVERY AND DEVELOPMENT MARKET 2014-2023 ($ MILLION)
36.    GLOBAL GENOTYPING MARKET BY PERSONALIZED MEDICINE MARKET 2014-2023 ($ MILLION)
37.    GLOBAL GENOTYPING MARKET BY OTHERS MARKET 2014-2023 ($ MILLION)
38.    UNITED STATES (U.S.) GENOTYPING MARKET 2014-2023 ($ MILLION)
39.    CANADA GENOTYPING MARKET 2014-2023 ($ MILLION)
40.    UNITED KINGDOM (UK) GENOTYPING MARKET 2014-2023 ($ MILLION)
41.    FRANCE GENOTYPING MARKET 2014-2023 ($ MILLION)
42.    GERMANY GENOTYPING MARKET 2014-2023 ($ MILLION)
43.    SPAIN GENOTYPING MARKET 2014-2023 ($ MILLION)
44.    ITALY GENOTYPING MARKET 2014-2023 ($ MILLION)
45.    ROE GENOTYPING MARKET 2014-2023 ($ MILLION)
46.    INDIA GENOTYPING MARKET 2014-2023 ($ MILLION)
47.    CHINA GENOTYPING MARKET 2014-2023 ($ MILLION)
48.    JAPAN GENOTYPING MARKET 2014-2023 ($ MILLION)
49.    KOREA GENOTYPING MARKET 2014-2023 ($ MILLION)
50.    AUSTRALIA GENOTYPING MARKET 2014-2023 ($ MILLION)
51.    ROAPAC GENOTYPING MARKET 2014-2023 ($ MILLION)
52.    LATIN AMERICA GENOTYPING MARKET 2014-2023 ($ MILLION)
53.    MENA GENOTYPING MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion